| Training Opportunities |
| Overview | Current Trainees | Prior Trainees Institutional Opportunities |
Prior Research Fellows and Trainees in Hematology and Medical Oncology
Research Fellows in Hematology and Medical Oncology
2006-2008
Nicole Whitlatch, MD
Research Project:1. NIH-funded clinical trial assessing the incidence of thromboembolic events in patients with Heparin-PF4 antibodies after cardiac bypass2. Identifying patients with HIT who are at high risk for thromboembolic events, using clinical algorithms and genomics/proteomicsRepresentative Publications:1. Perry SL, Whitlatch NL, Ortel TL. Clinical management and outcomes of patients with heparin/platelet factor 4 antibodies: retrospective review at a single center. Blood, 2006 (abstract accepted for poster presentation).
2005-2007
Veshana Ramiah, MD
Research Projects:
1. Genomic analysis of thrombotic risk in patients with malignancy
2. Gene expression strategies to identify patients at high risk for recurrent thrombosis
Awards:
Recipent, ASH Clinical Research Training Institute, 2006.
Representative Publications:
Potti A, Ramiah V, Ortel TL. Thrombophilia and Thrombosis in TTP. Semin.Thromb.Hemostasis, (in review).
Current Position:
Instructor, Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC
2004-2006
Elizabeth Krakow, MD
Research Project:Incidence of anti-heparin/platelet factor 4 antibodies and heparin-inducedthrombocytopenia following cardiopulmonary bypass procedures.Awards:Recipient, Primer Award (supported by Pfizer), 2004-2005.Current Position:Clinical Scholar, Division of Hematology, Department of Medicine, McMaster University and Hamilton Health Sciences
2004-2006 
Anil Potti, MBBS
Research Projects:1. Genomic analysis of thrombotic risk in patients with antiphospholipid syndrome.Representative Publications:1. Potti A, Rusconi CP, Sullenger BA, Ortel TL. Regulatable aptamers in medicine:focus on antithrombotic strategies. Expert Opin.Biol.Ther., 2004; 4: 1641-1647.2. Potti A, Danielson B, Badreddine R, Ortel T. Potassium homeostasis in patientsreceiving prophylactic dose enoxaparin therapy. J.Thromb.Haemost., 2004; 2: 1208-1209.Awards:Recipient, ASH Clinical Research Training Institute, 2004.Current Position:Faculty, Associate Professor in the Department of Medical Oncology, Duke University Medical Center, Durham, NC.
2002-2004
Zöe Larned, MD
Research Projects:1. Hypercoagulability associated with hormonal therapy in patients with breast cancer.Representative Publications:1. Larned ZL, O’Shea SI, Ortel TL. Heparin-Induced Thrombocytopenia: Clinical Presentations and Therapeutic Management. Clin. Adv. in Hematology & Oncology, 2003; 1: 356-364.Current Position:Ochsner Clinic, New Orleans, LA
2001-2003
Stephanie Perry, MD, PharmD
Research Projects:1. Monitoring anticoagulation in patients with lupus anticoagulants.2. Pharmacokinetic analysis of low-molecular weight heparin in patients withend-stage renal disease.Representative Publications:1. Perry SL, O’Shea SI, Ortel TL. Management of lepirudin therapy for a patient withantiphospholipid antibody syndrome using the whole blood ecarin clot time and aPTT.Blood Coag.Fibrinol., 2003; 14: 601-604.2. Lukes AS, Perry S, Ortel TL. von Willebrand’s disease diagnosed after menorrhagiaworsened from levonorgestrel intrauterine system. Obstet.Gynecol., 2005; 105: 1223-1226.Awards:Recipient, Mentored Clinical Research Scholars Program (K12 award), 2003-present.Current Position:Assistant Professor, Brain Tumor Center, Duke University Medical Center, Durham, NC.
2000-2002
Susan O’Shea, MBBS
Research Projects:1. Hypercoagulable states and antithrombotic strategies in hemodialysis-dependent patients.2. Expert-system based management strategy for patient self-management of oral anticoagulant therapy.Representative Publications:1. O’Shea SI, Ortel TL, Kovalik EC. Alternative methods of anticoagulation in dialysis-dependent patients with heparin induced thrombocytopenia. Semin. Dialysis, 2003; 16: 61-67.2. O’Shea SI, Lawson JH, Reddan D, Ortel TL. Hypercoagulable states and antithrombotic strategies in patients with recurrent vascular access thrombosis. J. Vasc. Surg., 2003; 38:541-548.Awards:Recipient, ASH Scholar Award, 2002-2004.Current Position:Acting Consultant Haematologist, Cork University Hospital, Cork, Ireland.





DHTS STRATEGIC WEB SERVICES